ACADIA PHARMACEUTICALS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2013 to Q3 2024.
  • Acadia Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $26.2M, a 41.1% increase year-over-year.
  • Acadia Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $74.6M, a 18.8% increase year-over-year.
  • Acadia Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $66.4M, a 2.61% decline from 2022.
  • Acadia Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $68.2M, a 7.21% increase from 2021.
  • Acadia Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $63.6M, a 24.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $74.6M $26.2M +$7.63M +41.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $67M $15.7M +$531K +3.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $66.5M $14.8M +$45K +0.31% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $66.4M $18M +$3.61M +25% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $62.8M $18.5M +$227K +1.24% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $62.6M $15.2M -$5.36M -26.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $67.9M $14.7M -$258K -1.72% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $68.2M $14.4M +$1.53M +11.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $66.7M $18.3M +$2.77M +17.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $63.9M $20.5M -$1.49M -6.79% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $65.4M $15M +$1.78M +13.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $63.6M $12.9M -$8.32M -39.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $71.9M $15.5M -$5.83M -27.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $77.8M $22M +$2.5M +12.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $75.3M $13.2M -$9.16M -41% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $84.4M $21.2M +$1.26M +6.31% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $83.2M $21.4M -$651K -2.96% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $83.8M $19.5M -$915K -4.48% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $84.7M $22.3M +$2.47M +12.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $82.3M $19.9M -$464K -2.27% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $82.7M $22M +$1.85M +9.19% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $80.9M $20.4M -$130K -0.63% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $81M $19.9M -$559K -2.74% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $81.6M $20.4M -$1.62M -7.35% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $83.2M $20.2M +$471K +2.39% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $82.7M $20.6M +$2.31M +12.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $80.4M $20.4M +$4.87M +31.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $75.5M $22M +$6.6M +42.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $68.9M $19.7M +$5.69M +40.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $63.2M $18.2M +$4.36M +31.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $58.9M $15.6M +$3.62M +30.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $55.3M $15.4M +$6.52M +73.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $48.7M $14M +$4.74M +51.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $44M $13.9M +$6.38M +85.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $37.6M $12M -$2.57M -17.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $40.2M $8.9M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $9.27M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $7.5M +$3.2M +74.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $14.5M +$11.4M +359% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q2 2014 $4.3M +$3.2M +291% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $3.16M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q2 2013 $1.1M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.